国: シンガポール
言語: 英語
ソース: HSA (Health Sciences Authority)
HEPATITIS A VIRUS ANTIGEN (INACTIVATED); HEPATITIS B SURFACE ANTIGEN (r-DNA)
GLAXOSMITHKLINE PTE LTD
J07BC20
720 elisa units/ml
INJECTION
HEPATITIS A VIRUS ANTIGEN (INACTIVATED) 720 elisa units/ml; HEPATITIS B SURFACE ANTIGEN (r-DNA) 20 mcg/ml
INTRAMUSCULAR
Prescription Only
GSK Biologicals, Branch of SmithKline Beecham Pharma GmbH & Co. KG (Primary Packager)
ACTIVE
1999-05-18
1 TWINRIX™ INACTIVATED HEPATITIS A AND RDNA HEPATITIS B VACCINE (ADSORBED) QUALITATIVE AND QUANTITATIVE COMPOSITION Suspension for injection. One dose (1.0ml) contains: Hepatitis A virus (inactivated) 1,2 720 ELISA Units Hepatitis B surface antigen 3,4 20 micrograms 1 Produced on human diploid (MRC-5) cells 2 Adsorbed on aluminium hydroxide, hydrated 0.05 milligrams Al 3+ 3 Produced in yeast cells (_Saccharomyces cerevisiae_) by recombinant DNA technology 4 Adsorbed on aluminium phosphate 0.4 milligrams Al 3+ TWINRIX™ is a white, slightly milky liquid presented in a glass vial or glass prefilled syringe PHARMACEUTICAL FORM Suspension for injection. CLINICAL PARTICULARS INDICATIONS TWINRIX™ is indicated for use in non immune adults and children aged from 1 year upwards, who are at risk of both hepatitis A and hepatitis B infection. DOSAGE AND ADMINISTRATION DOSAGE A dose of 1.0 ml TWINRIX™ is recommended for adults and children aged from 1 year upwards. _Primary vaccination schedule_ x Adults and adolescents of 16 years of age and above The standard primary course of vaccination with TWINRIX™ consists of three doses, the first administered at the elected date, the second one month later and the third six months after the first dose. In exceptional circumstances in adults, when travel is anticipated within one month or more after initiating the vaccination course, but where insufficient time is available to allow the standard 0, 1, 6 month schedule to be completed, a schedule of three intramuscular injections given at 0, 7 and 21 days may be used. When this schedule is applied, a fourth dose is recommended 12 months after the first dose. x Children of 1 to 15 years of age 2 The standard primary course of vaccination with TWINRIX™ consists of two doses, the first is administered a 完全なドキュメントを読む
_ _ 1 TWINRIX INACTIVATED HEPATITIS A AND RDNA HEPATITIS B VACCINE (ADSORBED) SUSPENSION FOR INJECTION QUALITATIVE AND QUANTITATIVE COMPOSITION Suspension for injection. One dose (1.0 ml) contains: Hepatitis A virus (inactivated) 1,2 720 ELISA Units Hepatitis B surface antigen 3,4 20 micrograms 1 Produced on human diploid (MRC-5) cells 2 Adsorbed on aluminium hydroxide, hydrated 0.05 milligrams Al 3+ 3 Produced in yeast cells (_Saccharomyces cerevisiae_) by recombinant DNA technology 4 Adsorbed on aluminium phosphate 0.4 milligrams Al 3+ TWINRIX is a white, slightly milky liquid presented in a glass pre-filled syringe. CLINICAL INFORMATION INDICATIONS TWINRIX is indicated for use in non-immune adults and children aged from 1 year upwards, who are at risk of both hepatitis A and hepatitis B infection. DOSAGE AND ADMINISTRATION _Dosage _ A dose of 1.0 ml TWINRIX is recommended for adults and children aged from 1 year upwards. _ _ _Primary vaccination schedule _ _Adults and adolescents of 16 years of age and above _ The standard primary course of vaccination with TWINRIX consists of three doses, the first administered at the elected date, the second one month later and the third six months after the first dose._ _ In exceptional circumstances in adults, when travel is anticipated within one month or more after initiating the vaccination course, but where insufficient time is available to allow the standard 0, 1, 6 months schedule to be completed, a schedule of three intramuscular injections given at 0, 7 and 21 days may be used. When this schedule is applied, a fourth dose is recommended 12 months after the first dose. _Children and adolescents of 1 to 15 years of age _ The standard primary course of vaccination with TWINRIX consists of two doses, the first is administered at the elected date and the second between six and twelve months after the first dose. Protection against hepatitis B infections may not be obtained until after the second dose. Therefore, TWINRIX should be used only when there is a relati 完全なドキュメントを読む